| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |